Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Imexon

EU orphan designation number: EU/3/05/341   
Active ingredient: Imexon
Indication: Treatment of ovarian cancer
Sponsor: ICON Clinical Research (U.K.) Limited
2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/01/2006 Centralised Orphan - Designation EMEA/OD/065/05 (2005)6002 of 23/12/2005